Skip to main content

Table 1 Clear cell carcinoma arising from endometriosis of the scar caesarean section

From: Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature

 

Age

Previous uterine surgeries

Months since symptoms

Size cm

FNA or biopsy

Primary treatment

Pathology

Adjuvant treatment

Relapse

Death

Schnieber Agner-Kolb 1986 [4]

40

1 CS 15 years before

WE, BSO, Hys

Mass: CCC + endometriosis

Ovaries and uterus: negative

RT, progestins

Yes after 18 months

Hitti, 1996 [5]

46

1 CS 14 years before

1 CS 12 years before

6

WE, BSO, Hys

CCC + endometriosis

RT

No after 30 months

No after 30 months

Miller 1998 [6]

38

1 hysterotomy 9 years before

1 abortion 3 years before

1 CS 2 years before

8

4

CCC + endometriosis

WE, BSO, Hys omentectomy

Scar: CCC

Ovaries, uterus, omentum: negative

Margins: close

CIS-based CT

RT

No after 60 monthsd

No after 60 monthsd

Park 1999 [7]

56

1 CS 24 years

1 CS 20 years

5

WE

Mass: CCC + endometriosis

RT

Ishida 2003 [8]

56

1 CS 24 years

1 CS 20 years

7

10

Endometrial carcinoma

WE, Hys, BSO

Mass: CCC

Ovaries and uterus: negative

CIS-based CT

Yes after 24 monthsb

Sergent 2006 [9]

45

1 CS 25 years

1 CS 23 years

2 excisions of benign endometriosis nodules at the scar

17

20

WE, BSO,

later on: endometrial curettage

Mass: CCC + endometriosis

Right ovary: benign endometriosis; left ovary and uterus: negative

Margins: 1 cm free

Not done

Yes early after surgerya

Yes after 6 months

Alberto 2006 [10]

38

1 CS 11 years

BSO, Hys for endometriosis

6

6

WE

CCC

Carbo/PTX

RT

Razzouk 2007 [11]

46

1 CS 26 years before

1 CS 24 years before

2 excisions of endometriosis nodules at the scar

>20

GnRh analogue without benefit WE, BSO

Mass: CCC + endometriosis

Ovaries: negative

LN: 1 positive

Carbo/PTX

Yes during CT

Yes after 6 monthsb

Rust 2008 [12]

42

3 CS

Hys 5 years before

24

5

Carcinoma

WE

Mass: CCC + endometriosis

Margins: 1 mm free

Not done

Bats 2008 [13]

38

1 CS 13 years before

1 excision of endometriosic nodule at the scar

10

Atypical cells

NACT (carbo/PTX)

No benefit WE, BSO, Hys, omentectomy

Mass: CCC + endometriosis

Uterus: adenomyosis

Other specimens: negative

Margins: 2 mm free

Not done

Yes after 4 monthsa

Williams 2009 [14]

53

1 CS 17 years before

24

2.5

CCC (excisional biopsy)

WE of the scar, BSO, Hys, omentectomy

Inguinal/Pelvic LNctomy

Mass: CCC

Uterus, right ovary, omentum: negative, left ovary: teratoma

Inguinal LN: 7 positive/11

Pelvic LN: 8 positive/14

Carbo/PTX (4 cycles)

Yes after 3 monthsa

Yes after 11 monthsb

Bourdel 2010 [15]

43

1 CS 20 years before

1 CS 15 years before

1 excision of endometriosic nodule at the scar

9

9

WE, partial resection of pubic symphysis, umbilicus, right rectus abdomen, pelvic LN sampling

Later on: BSO, Hys

Mass: CCC + endometriosis

Pelvic LN: multiple positive

Ovaries, uterus: negative

Carbo/PTX (6 cycles)

RT

Yes after 6 monthsd

Yes after 22 monthsb

Yan 2011 [16]

41

2 CS 5 years before

2 excisions of benign endometriosic nodule at the scar 1 year and 4 months before

4

9

Not done

Progestins without benefit WE

Mass: CCC

CT

No after 24 monthsd

No after 24 monthsd

Li 2012 [17]

49

1 CS 26 years before

25 years

9

Not done

WE, Hys, BSO

Mass: CCC

Uterus, ovaries: negative

Carbo/PTX (6 cycles)

Noc after 8 months

Noc after 8 months

Mert 2012 [19]

42

Tubal ligation, right ovariectomy

15

Tumor cells Mullerian origin

NACT (carbo/PTX) WE, left SO Hys, left Pelvic LNctomy Omentectomy

Mass: CCC + endometriosis

Other organs: negative

Margins: free

Not done

No after 1 montha

No After 1 montha

 

51

2 CS Hys for myomas

12

6

Excisional biopsy CCC + endometriosis

BSO, Omental biopsy

Negative

Margins: free

RT

No after 31 monthsb

No after 31 monthsb

Shalin 2012 [18]

47

1 CS

10

3

CCC

WE, left ovary cystectomy, endometrial biopsy, pelvic LN sampling

Mass: CCC + endometriosis

Ovarian cyst: endometriosis

Endometrium: negative

Pelvic LN: 2 positive/4

Margins: positive

CIS-based CT (6 cycles)

RT

Yes after 5 monthsb

No after 7 monthsb

Ijichi 2014 [20]

60

1 CS 37 years before

1 CS 35 years before

48

4

Atypical cells

WE

Mass: CCC + endometriosis

Margins: free

Not done

Yes after 8 monthsa

No after 23 monthsa

Aust 2015 [21]

47

1 CS 16 years before

vaginal Hys 10 yearsbefore

6

10

WE Later on: BSO, pelvic, aortic LNctomy omentectomy

Mass: CCC

Ovaries and omentum: negative

LN:2 positive/48

Margins: free

Carbo/PTX (6 cycles)

No after 10 monthsc

No after 10 monthsc

Heller 2014 [22]

37

1 CS

1 CS

1 CS 8 years before

96*

18

CCC

WE, left SO, pelvic LNctomy

Mass: CCC

Ovary: negative

LFN: multiple LN positive

Refused treatment

Yes after 5 monthsa

Liu 2014 [23]

39

1 CS

1 excision of endometriosic nodule at the scar

60

6

WE, partial cystectomy, BSO, Hys, omentectomy, inguinal,pelvic, aortic LNctomy

Mass: CCC + endometriosis

Ovaries, uterus, omentum: negative

Bladder: positive

Pelvic LN: 18 positive/21

Aortic LN: 6 positive /6

Inguinal LN: 8 positive/8

Carbo/PTX (3 cycles)

YES after 10 monthsc

Yes after 12 monthsc

Sosa-Duràn 2015 [24]

45

1 CS

1 CS

1 CS

6

9

WE, margins: 2 cm free

Mass: CCC + endometriosis

Not done

No after 16 monthsa

No after 16 monthsa

Current case

44

1 CS 9 years before

8

22

Endometrial carcinoma

NACT (carbo/PTX)

WE, BSO, Hys, inguinal, and pelvic LNctomy

Mass: CCC + endometriosis

Ovaries, uterus: negative

Pelvic LN: 7 positive/14

Inguinal LN: 8 positive/11

Margins: free

Not done

Yes after 2 months from surgery

Yes after 6 months

  1. CCC clear cell carcinoma, CS caesarean section, WE wide mass excision, BSO bilateral salpingo-oophorectomy, SO salpingo-oophorectomy, Hys hysterectomy, LNctomy lymphadenectomy, LN lymph node, Carbo carboplatin, CIS cisplatin, PTX paclitaxel, RT radiotherapy
  2. *The mass was reported to have come and gone over the last 8 years since the last CS
  3. aFrom surgical resection
  4. bFrom initial diagnosis
  5. cSince completion of chemotherapy
  6. dNot specified